| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―09 |
Unique and Shared Patterns of Chemosensory Dysfunction Distinguish Chronic COVID-19 and Aspirin-Exacerbated Respiratory Disease |
Dante G. Minichetti, Tiffany Dharia, Amelia Boyd, Alyson Brown, Alexander Perniss, Evan Lemire, Adam L. Haber, Rachel E. Roditi, Stella E. Lee, Valentina Parma, Kathleen M. Buchheit, Tanya M. Laidlaw, Lora G. Bankova |
| 2 |
[GO] |
2026―Feb―28 |
Effect of background asthma and allergic conditions on prophylaxis and treatment of COVID-19 infection |
Ruifeng Chen, Kasturi Talapatra, Shazia Ali, Jiangnan Lyu, Eleftherios Mylonakis, Thomas Norton, Gregory P. Geba |
| 3 |
[GO] |
2025―Nov―05 |
COVID-19 VACCINATION IS ASSOCIATED WITH REDUCED COMPLICATIONS IN PEDIATRIC PATIENTS WITH ATOPIC DERMATITIS |
T. Nguyen, T. Kumala, P. Nguyen, H. Chan, A. Pham, J. Wang, Y. Tanas, Z. Yang |
| 4 |
[GO] |
2025―Nov―05 |
ASTHMA EXACERBATION TRENDS: SUPPRESSION DURING COVID-19 STATE OF EMERGENCY, NOW FACING REBOUND BEYOND PRE-PANDEMIC RATES |
N. Wozny, M. Cardona, R. Hopp, H. Niebur, J. Lee |
| 5 |
[GO] |
2025―Sep―01 |
Risk of asthma in US adults with COVID-19 in real-world settings |
Yi-Sheng Jhang, Hui-Chin Chang, Shuo-Yan Gau |
| 6 |
[GO] |
2025―Jun―21 |
Increased Likelihood of COVID-19-Related Asthma Exacerbation with Higher Eosinophil Count |
Mirna Ayache, Faiza Khalid |
| 7 |
[GO] |
2025―Mar―15 |
Increased asthma burden during and post the COVID-19 pandemic among U.S. adults |
Hongxuan Fan, Zhaoyu Ren, Ping Zhang, Boda Zhou |
| 8 |
[GO] |
2024―Dec―07 |
Corrigendum to ‘Inflammatory pathways in patients with post-acute sequelae of COVID-19’ [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515] |
Matthew R. Elliott, Anna E. O'Connor, Gailen D. Marshall |
| 9 |
[GO] |
2024―Nov―01 |
Post-pandemic, long COVID persists |
Donald Y.M. Leung |
| 10 |
[GO] |
2024―Oct―25 |
A CASE OF SYSTEMIC CAPILLARY LEAK SYNDROME (SCLS) IN THE SETTING OF COVID-19 |
P. Retnakumar, B. Navetta-Modrov |
| 11 |
[GO] |
2024―Oct―25 |
ASSOCIATION OF COMORBID ASTHMA TO IN-HOSPITAL OUTCOMES IN PATIENTS HOSPITALIZED FOR COVID-19 INFECTION |
A. Siwakoti, S. Khadka, M. Uprety, S. Giri |
| 12 |
[GO] |
2024―Oct―25 |
IMPACT OF SARS-COVID 19 INFECTION ON IMMUNE PARAMETERS OF UROLITHIASIS PATIENTS |
T. Poroshina, V. Driianska, O. Vozianov, V. Savchuk, D. Chernenko, L. DuBuske |
| 13 |
[GO] |
2024―Oct―25 |
EMERGENCY DEPARTMENT VISITS FOR PEDIATRIC FOOD ALLERGIES DURING THE COVID 19 PANDEMIC |
J. Devera, C. Esteban, G. Cushman, S. Chandra, M. Scarpaci, T. Zheng, D. Barker, E. McQuaid |
| 14 |
[GO] |
2024―Oct―25 |
STRATIFYING RISK FOR LONG COVID IN PATIENTS WITH IMMUNODEFICIENCY |
M. Aglan, K. Gilbert, M. Ong, J. Farmer |
| 15 |
[GO] |
2024―Aug―23 |
“Inflammatory Pathways in Patients with Post-acute Sequelae of COVID-19 - The Role of the Clinical Immunologist” |
Matthew R. Elliott, Anna E. O'Connor, Gailen D. Marshall |
| 16 |
[GO] |
2024―Aug―09 |
Long COVID in pediatric patients with chronic health issues: How to assess and support. |
Joy Goldberg, Nathan Rabinovitch, Bruce Bender |
| 17 |
[GO] |
2024―Jan―21 |
Association between allergic conditions and COVID-19 susceptibility and outcomes |
Chao Chen, Xue Song, Dana J. Murdock, Andrea Marcus, Mohamed Hussein, Jessica J. Jalbert, Gregory P. Geba |
| 18 |
[GO] |
2024―Jan―18 |
The Impact of Coronavirus Disease 2019 (COVID-19) Vaccine Reactions on Secondary Vaccine Hesitancy |
Esther E. Freeman, Alexis G. Strahan, Liam R. Smith, Allen D. Judd, Upeka Samarakoon, Geoffrey Chen, Andrew J. King, Kimberly G. Blumenthal |
| 19 |
[GO] |
2023―Dec―03 |
Case series of patients with acute and chronic urticaria after COVID-19 vaccination |
Andrew Nickels, Supriya Varadarajulu, Pamela Harris, Alexandra Graden, Annely Richardson, Trisha Saha, Elyse O Kharbanda, Jingyi Zhu, Gabriela Vazquez-Benitez |
| 20 |
[GO] |
2023―Nov―09 |
AGE, SEX, OBESITY, AND CONTROLLER THERAPY MODERATE THE RELATIONSHIP BETWEEN PEDIATRIC ASTHMA EXACERBATIONS AND COVID-19 |
J. Barrows, S. Galant, T. Morphew |
| 21 |
[GO] |
2023―Nov―09 |
ASSESSING SEVERITY OF COVID-19 AND THE DEVELOPMENT OF MIS-C IN PEDIATRIC PATIENTS WITH ATOPIC DISEASE |
N. Rudsenske, J. Perkins |
| 22 |
[GO] |
2023―Nov―09 |
INCIDENCE AND PREDICTORS OF CUTANEOUS REACTIONS TO THE COVID-19 BOOSTER VACCINE |
R. Shah, A. King, E. Shenoy, A. Landman, D. Hashimoto, K. Blumenthal |
| 23 |
[GO] |
2023―Nov―09 |
PROTEIN LOSING ENTEROPATHY, HYPOALBUMINEMIA, HYPOGAMMAGLOBULINEMIA AND ANASARCA ASSOCIATED WITH RECURRENT COVID-19 INFECTION |
C. Gunderson, C. Chang, N. Hamburger |
| 24 |
[GO] |
2023―Nov―09 |
UNDEFINED AUTOINFLAMMATORY CONDITION FOLLOWING COVID-19 INFECTION |
O. Humpel, L. Nagireddi, R. Hostoffer |
| 25 |
[GO] |
2023―Nov―09 |
FROM SEVERE COVID-19 INFECTION TO GENETIC REVELATION: TOLL-LIKE RECEPTOR 7 DEFICIENCY IN TWO BROTHERS |
B. Schornack, M. Leondaridis, J. McMurray, N. Boggs, A. Snow |
| 26 |
[GO] |
2023―Nov―09 |
GRAFT-VERSUS-HOST-DISEASE - A RARE COVID-19 MRNA VACCINE SIDE EFFECT IN POST STEM CELL TRANSPLANT PATIENTS |
K. Sese |
| 27 |
[GO] |
2023―Nov―09 |
THE EFFECT OF COVID-19 ON PEDIATRIC ASTHMA ICU ADMISSIONS AT A SINGLE CENTER. |
P. Le |
| 28 |
[GO] |
2023―Nov―09 |
ALLERGY IMMUNOLOGY FELLOWSHIP EDUCATION DURING COVID-19 PANDEMIC |
A. Yeich, M. Matheny, N. Maglakelidze, L. Mazur, T. Craig |
| 29 |
[GO] |
2023―Nov―09 |
SARS-COV2 SPECIFIC ANTIBODY RESPONSES TO COVID-19 VACCINATION IN COMMON VARIABLE IMMUNODEFICIENCY |
K. Zhang, S. Agrawal, S. Gupta |
| 30 |
[GO] |
2023―Nov―09 |
AUTOIMMUNE RESPONSE TO THE COVID-19 VACCINE ELICITING VITILIGO |
A. Mittman |
| 31 |
[GO] |
2023―Nov―09 |
DOUBLE BLIND RANDOMIZED CONTROLLED TRIAL OF SALINE SOLUTION GARGLING AND NASAL RINSING IN SARS-COV-2 INFECTION |
S. Espinoza, L. Trauffler, A. Shamshirsaz, A. Shamshirsaz, A. Espinoza, J. Espinoza, A. O'Brien |
| 32 |
[GO] |
2023―Nov―09 |
EFFECT OF THE SARS-COV-2 PANDEMIC ON PEDIATRIC ASTHMA HEALTH-CARE UTILIZATION IN AN URBAN TERTIARY-CARE HOSPITAL |
H. Zomer Bolanos, M. Reznik, E. Rothschild, L. Conrad, M. Cabana |
| 33 |
[GO] |
2023―Nov―09 |
CD14 (C-159)T GENE POLYMORPHISM IN SARS-COV-2 PATIENTS IN CRIMEA |
V. Beloglazov, I. Yatskov, L. Dudchenko, E. Ageeva, L. DuBuske |
| 34 |
[GO] |
2023―Nov―09 |
THE NOISE ABOUT SARS-COV-2 VACCINATION: A RETROSPECTIVE COHORT STUDY EVALUATING TINNITUS AND VACCINATION |
J. Pollock, D. Hoffman, A. Tolisano, L. Housel, R. Lee |
| 35 |
[GO] |
2023―Nov―09 |
FREQUENCY OF T-330G IL-2 GENE SNP IN SARS-COVID-19 PATIENTS |
V. Beloglazov, I. Yatskov, E. Ageeva, L. DuBuske |
| 36 |
[GO] |
2023―Aug―23 |
Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US |
Adam Gaffney, David U. Himmelstein, Steffie Woolhandler |
| 37 |
[GO] |
2023―Aug―07 |
Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up |
Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova |
| 38 |
[GO] |
2023―Aug―01 |
Did the coronavirus disease 2019 pandemic change asthma prevalence? |
Rebecca Koenigsberg, Mitchell H. Grayson |
| 39 |
[GO] |
2023―Jul―05 |
Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study |
Dr Virginia Hernandez Santiago, Dr Adeniyi Francis Fagbamigbe, Prof Frank Sullivan, Dr Utkarsh Agrawal, Dr Daniel Morales, Prof Colin McCowan, Prof Brian Lipworth |
| 40 |
[GO] |
2023―Jun―15 |
Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children |
Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant |
| 41 |
[GO] |
2023―May―03 |
Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study |
Martín Bedolla-Barajas, Jaime Morales-Romero, Martín Robles-Figueroa, Tonatiuh Delgado-Figueroa |
| 42 |
[GO] |
2023―Apr―19 |
Asthma medication adherence during the COVID-19 pandemic in children at high risk of exacerbation |
Colleen M Shannon, Carina Flaherty, William O Quarshie, Rui Xiao, Chén C Kenyon |
| 43 |
[GO] |
2023―Apr―07 |
COVID-19 vaccine skin testing and graded challenges in vaccine hesitant patients |
Ari Heffes-Doon, Nathanael Horne, Chinyere Okpara, Meredith Akerman, Luz Fonacier |
| 44 |
[GO] |
2023―Mar―15 |
The Role of IL-13 and the Type 2 Immune Pathway in COVID-19: A Review |
Jennifer Sasson, G. Brett Moreau, William A. Petri |
| 45 |
[GO] |
2023―Feb―02 |
Antibody and T-cell responses to COVID-19 Vaccination in Common Variable Immunodeficiency and Specific Antibody Deficiency |
Jamie A. Rosenthal, Michelle Premazzi Papa, Marta Sanz, Samuel Nicholes, Carissa Stower, Alberto Bosque, Anjeni Keswani, Richard Amdur, Rebecca M. Lynch, Natalia Soriano-Sarabia, Daniel Ein |
| 46 |
[GO] |
2022―Dec―10 |
Impact of Vaccination against SARS-CoV-2 on the Atopic Dermatitis Serum Proteome |
Madeline Kim, Benjamin Ungar, Yeriel Estrada, Ana B. Pavel, Emma Guttman-Yassky |
| 47 |
[GO] |
2022―Dec―01 |
Is there value in coronavirus disease 2019 vaccine and vaccine excipient skin testing or split dosing? |
Matthew Greenhawt |
| 48 |
[GO] |
2022―Dec―01 |
Split-dosing of coronavirus disease 2019 vaccines |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 49 |
[GO] |
2022―Nov―10 |
DETERIORATION OF RESPIRATORY STATUS IN A CVID PATIENT WITH GLILD AND COVID-19 |
N. Kimura, A. Jongco |
| 50 |
[GO] |
2022―Nov―10 |
A CASE SERIES: CHRONIC INDUCIBLE URTICARIA FOLLOWING COVID-19 INFECTION AND MRNA VACCINE |
T. Hellu, S. Weiss, K. Adams |
| 51 |
[GO] |
2022―Nov―10 |
A CASE OF PULMONARY EMBOLISM POST COVID-19 INFECTION IN A PATIENT WITH STAT3 MUTATION |
H. Blunk, K. Birch, M. Callahan, R. Hostoffer |
| 52 |
[GO] |
2022―Nov―10 |
THE IMPORTANCE OF B CELLS IN OVERCOMING COVID-19 INFECTION IN COMMON VARIABLE IMMUNODEFICIENCY PATIENTS. |
J. Brozyna, H. Li, A. Hassoun, F. Ibrahim |
| 53 |
[GO] |
2022―Nov―10 |
INCIDENCE OF COVID-19 INFECTIONS IN ADULTS WITH PRIMARY IMMUNODEFICIENCY AFTER RECEIVING TIXAGEVIMAB AND CILGAVIMAB |
S. Johnson, J. Fernandez |
| 54 |
[GO] |
2022―Nov―10 |
OUTCOMES AND IMPACT OF COVID-19 ON INFECTION DIAGNOSIS RATES AMONG PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES |
F. Riaz, K. Umashankar, E. Marchlewicz, K. Zhang, M. Sanchirico |
| 55 |
[GO] |
2022―Nov―10 |
LIKELIHOOD OF DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS VIA ENDOSCOPY IN DYSPHAGIA DURING THE COVID-19 PANDEMIC |
J. Brennan, K. Yamada, T. Al-Shaikhly, G. Ghaffari |
| 56 |
[GO] |
2022―Nov―10 |
THE IMPACT OF COVID-19 PANDEMIC ISOLATION MEASURES ON PEDIATRIC ASTHMA ADMISSIONS |
S. Raja, V. Nguyen, R. Heinle, J. Hossain |
| 57 |
[GO] |
2022―Nov―10 |
BIOMARKERS OF CYTOKINE STORM AND INFLAMMATION IN SEPSIS, POST-COVID-19 PATIENTS AND COVID-19 VACCINATED INDIVIDUALS |
L. Titov, M. Trusevich, T. Amvrosieva, I. Belskaya, Y. Gorbich, L. DuBuske |
| 58 |
[GO] |
2022―Nov―10 |
POLYMYALGIA RHEUMATICA AFTER MRNA COVID-19 VACCINATION |
N. Trotto, S. Hauk, S. Fowler, B. McGoey, J. Ravell |
| 59 |
[GO] |
2022―Nov―10 |
SECONDARY URTICARIAL VASCULITIS AND CHRONIC SPONTANEOUS URTICARIA ASSOCIATED WITH COVID-19 VACCINATION |
T. Chang, F. Tachibana, V. Wang, J. Yusin |
| 60 |
[GO] |
2022―Nov―10 |
PRE-VACCINE COUNSELING TO ASSIST WITH RISK ASSESSMENT PRIOR TO COVID-19 VACCINATION |
J. Rosenblum, C. Yie, M. Akerman, E. Banta |
| 61 |
[GO] |
2022―Nov―10 |
PERSISTENT ANGIOEDEMA AFTER COVID-19 VACCINATION: IS BRADYKININ TO BLAME? |
G. Edland, S. Awan, A. James, A. Keswani |
| 62 |
[GO] |
2022―Nov―10 |
COVID-19 VACCINE ADMINISTRATION IN PATIENTS WITH FIRST-DOSE ADVERSE REACTIONS OR HISTORY OF SEVERE ALLERGIC REACTION |
K. Vanijcharoenkarn, F. Lee, M. Kalangara |
| 63 |
[GO] |
2022―Nov―10 |
COVID-19 VACCINE REACTIONS AND SUSPECTED POLYETHYLENE GLYCOL ALLERGY: A PEDIATRIC CASE SERIES |
M. Laditan, A. Martone, D. Doshi |
| 64 |
[GO] |
2022―Nov―10 |
REDUCED COVID-19 VACCINE RESPONSE IN PATIENT TREATED WITH DUPILUMAB FOR IGG4 RELATED DISEASE. |
A. Abadeh, J. Lee |
| 65 |
[GO] |
2022―Nov―10 |
MRNA COVID-19 VACCINE-ASSOCIATED BULLOUS FIXED DRUG ERUPTION |
S. Imam, T. Carpenter, A. Wolff, R. Khianey, E. Capitle |
| 66 |
[GO] |
2022―Nov―10 |
RISK OF ANAPHYLAXIS TO THE COMPONENTS OF THE COVID-19 VACCINE: A STUDY IN MEXICAN POPULATION |
R. Lopez Henriquez, J. Uc Rosado, S. Gonzalez-Diaz, R. Villarreal Gonzalez, C. De Lira-Quezada, A. Macias-Weinmann, C. Macouzet-Sanchez, T. Delgado Guzmán |
| 67 |
[GO] |
2022―Nov―10 |
REVISITING HYPERSENSITIVITY REACTIONS TO THE MRNA COVID-19 VACCINE: TOLERANCE AFTER PREVIOUS HISTORY OF ANAPHYLAXIS |
I. AlOtaibi, F. ALMuhizi, S. Ton-Leclerc, M. Fein, M. Ben-Shoshan, G. Isabwe, A. Copaescu |
| 68 |
[GO] |
2022―Nov―10 |
SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING |
A. Musa, M. Wood, S. May, A. Rorie, J. Van De Graaff, R. Walenz, P. Fey, J. Poole |
| 69 |
[GO] |
2022―Nov―10 |
IMMUNIZATION STRESS-RELATED RESPONSES DURING SKIN TESTING AND CHALLENGE TO COVID-19 VACCINES: A CASE SERIES |
H. Jin, L. Fonacier |
| 70 |
[GO] |
2022―Nov―10 |
TOLERABILITY OF GRADED CORONAVIRUS DISEASE 2019 MRNA VACCINE DOSING |
B. Hamel, M. Pitlick, A. Joshi |
| 71 |
[GO] |
2022―Nov―10 |
BRACHIAL NEURITIS FROM THE MRNA SARS-COV-2 AND INFLUENZA VACCINES |
J. VanLancker, D. Sheth |
| 72 |
[GO] |
2022―Nov―10 |
SARS-COV-2 ANTIBODY LEVELS CONTINUE TO RISE IN IMMUNE GLOBULIN PREPARATIONS |
Q. Wang, H. Park |
| 73 |
[GO] |
2022―Nov―10 |
SARS-COV-2 INFECTION ASSOCIATED WITH NEW SEVERE HYPEREOSINOPHILIA AND MULTIPLE ORGAN DAMAGE |
J. Eremija, N. Odisho Domit, T. Carr |
| 74 |
[GO] |
2022―Nov―10 |
RESISTANCE TO GLUCOCORTICOSTEROID THERAPY IN PATIENTS WITH SARS-COV-2 INFECTION WITH ELEVATED MARKERS OF ENDOTOXEMIA |
V. Beloglazov, I. Yatskov, L. DuBuske |
| 75 |
[GO] |
2022―Nov―01 |
The intersection of the sunshine act, sutton's law, and the pandemic |
Marcus Shaker |
| 76 |
[GO] |
2022―Oct―22 |
COVID-19 patients are characterized by dysregulated levels of membrane and soluble CD48 |
Hadas Pahima, Ilan Zaffran, Eli Ben-Chetrit, Amir Jarjoui, Pratibha Gaur, Maria Laura Manca, Dana Reichmann, Efrat Orenbuch-Harroch, Ekaterini Tiligada, Ilaria Puxeddu, Carl Zinner, Alexandar Tzankov, Francesca Levi-Schaffer |
| 77 |
[GO] |
2022―Oct―12 |
Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination and comparison of BNT162b2 with mRNA-1273 |
Samuel M. Ailsworth, Behnam Keshavarz, Nathan E. Richards, Lisa J. Workman, Deborah D. Murphy, Michael R. Nelson, Thomas A.E. Platts-Mills, Jeffrey M. Wilson |
| 78 |
[GO] |
2022―Sep―07 |
Split-Dosing of COVID-19 Vaccines Provides Non-Inferior Antibody Responsiveness to Conventional Vaccine Dosing |
Amal Musa, Macy Wood, Andrew Rorie, Sara M. May, Joel Van De Graaff, Jill A. Poole |
| 79 |
[GO] |
2022―Aug―18 |
Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 80 |
[GO] |
2022―Aug―13 |
Industry Payments to Allergists and Clinical Immunologists in the United States during the COVID-19 pandemic |
Anju Murayama, Sae Kamamoto, Hiroaki Saito, Tetsuya Tanimoto, Akihiko Ozaki |
| 81 |
[GO] |
2022―Jul―30 |
Anxiety in Adults with Allergic Rhinitis During the Coronavirus Disease 2019 Pandemic: A Canadian Perspective |
Kayley Xu, Sophia Linton, Adam Sunavsky, Sarah Garvey, Hannah Botting, Lisa M Steacy, Wilma M Hopman, Dean A Tripp, Anne K Ellis |
| 82 |
[GO] |
2022―Jul―23 |
Causation or coincidence? Phenotype of asthma exacerbations during the coronavirus disease 2019 pandemic |
Christian Coletta, Mitchell H. Grayson |
| 83 |
[GO] |
2022―Jul―23 |
Lessons from the IMPAACT of coronavirus disease 2019 public health restrictions on food allergy-associated anxiety |
Michael A. Golding, Jennifer L.P. Protudjer |
| 84 |
[GO] |
2022―Jul―17 |
Patch Testing Results in Adult Patients with Dermatitis during the COVID-19 Pandemic |
Stephanie Kong, Stephanie L Mawhirt |
| 85 |
[GO] |
2022―Jun―16 |
Immunizing the Imperfect Immune System: COVID-19 Vaccination in Patients with Inborn Errors of Immunity |
Jessica R. Durkee-Shock, Michael D. Keller |
| 86 |
[GO] |
2022―May―28 |
Predictors of seroconversion following COVID-19 vaccination |
Sergio E. Chiarella, Sarah M. Jenkins, Carin Y. Smith, Vikas Prasad, Fnu Shakuntulla, Vaibhav Ahluwalia, Vivek N. Iyer, Elitza S. Theel, Avni Y. Joshi |
| 87 |
[GO] |
2022―May―21 |
Allergic Reactions to the COVID-19 vaccine (ARCOV) study: the McGill University Health Center (MUHC) experience |
Faisal ALMuhizi, Michael Fein, Sofianne Gabrielli, Louise Gilbert, Christos Tsoukas, Moshe Ben-Shoshan, Ana M. Copaescu, Ghislaine A.C Isabwe |
| 88 |
[GO] |
2022―May―20 |
A case of coronavirus disease 2019 messenger RNA vaccine tolerance and immune response despite presence of anti-polyethylene glycol antibodies |
Kristen B. Corey, Grace Koo, Cosby A. Stone, Susan F. Kroop, William H. Fissell, Steven Kozlowski, Zhao-Hua Zhou, Elizabeth J. Phillips |
| 89 |
[GO] |
2022―May―20 |
The Role of the Allergist in Coronavirus Disease 2019 Vaccine Allergy Safety |
Valerie Chiang, Chinmoy Saha, Jackie Yim, Elaine Y.L. Au, Andy K.C. Kan, Kong Siu Harris Hui, Tin Sum Li, Wing Lam Whitney Lo, Yuh Dong Hong, Jiaxi Ye, Carmen Ng, Welchie W.K. Ko, Carmen T.K. Ho, Chak Sing Lau, Jianchao Quan, Philip H. Li |
| 90 |
[GO] |
2022―May―19 |
Outcomes of Allergic Type Reactions Following mRNA COVID-19 Vaccination at Three Military Medical Centers |
Benjamin D. St Clair, Donna L. Hoffman, Bruce McClenathan, Taylor Banks, Rachel U. Lee |
| 91 |
[GO] |
2022―May―17 |
Antibody Response to Graded Dosing of COVID-19 mRNA Vaccines After Allergic Reaction to First Dose |
Sara W Van Meerbeke, Merritt L Fajt, Rachel V Marini, Robyn T Domsic, Andrej A Petrov |
| 92 |
[GO] |
2022―Apr―23 |
COVID-19 Related Anxiety Is Associated with Uncontrolled Asthma in Adults |
Kamal M Eldeirawi, Sharmilee M. Nyenhuis, Luz Huntington-Moskos, Barbara J. Polivka |
| 93 |
[GO] |
2022―Apr―23 |
Decreased food-allergy-specific anxiety and increased general anxiety in parents of children with food allergies during COVID-19 |
Clara Westwell-Roper, Sharon To, Lianne Soller, Edmond S. Chan, S. Evelyn Stewart |
| 94 |
[GO] |
2022―Apr―08 |
Effect of the COVID-19 pandemic on morbidity among children hospitalized for an asthma exacerbation |
Nada Alabdulkarim, Jiaxiang Gai, James Bost, Dinesh Pillai, Stephen J. Teach, Deepa Rastogi |
| 95 |
[GO] |
2022―Apr―06 |
Specific antibody response of 14 common variable immunodeficiency patients to three BNT162b2 mRNA COVID-19 vaccinations |
Nizar Abo-Helo, Emad Muhammad, Sondus Ghaben-Amara, Shai Cohen |
| 96 |
[GO] |
2022―Apr―05 |
One year later: What Have We Learned About the Allergenicity and Adverse Reactions Associated with the SARS-CoV-2 vaccines |
Ana M Copaescu, Jaime S Rosa Duque, Elizabeth J. Phillips |
| 97 |
[GO] |
2022―Mar―26 |
The impact of dupilumab treatment on SARS-CoV-2/COVID-19 antibody responses in atopic dermatitis patients |
Benjamin Ungar, Leore Lavin, Alexandra K. Golant, Alyssa Gontzes, Eden David, Yeriel D. Estrada, Giselle K. Singer, Ana B. Pavel, Emma Guttman-Yassky |
| 98 |
[GO] |
2022―Mar―25 |
Asthma and COVID-19 related outcomes in hospitalized patients: A single center experience |
Amy Ludwig, Caryn Brehm, Christopher Fung, Shijing Jia, Jonathan P. Troost, Laura Leuenberger, Rayan Kaakati, Catherine Tarantine, Ella Christoph, Michael W. Sjoding, Njira Lugogo |
| 99 |
[GO] |
2022―Mar―12 |
COVID-19 Vaccine Administration in Patients with Reported Reactions to Polyethylene Glycol- and Polysorbate-Containing Therapeutics |
Iris M. Otani, Lulu R. Tsao, Monica Tang |
| 100 |
[GO] |
2022―Mar―04 |
Social Well-Being Amongst Children With vs. Without Food Allergy Before and During COVID-19 |
Kaitlyn A. Merrill, Elissa M. Abrams, Elinor Simons, Jennifer Lisa Penner Protudjer |
| 101 |
[GO] |
2022―Mar―04 |
Graded COVID-19 Vaccine Administration: A Safe Alternative to Vaccine Avoidance |
Mitchell M. Pitlick, Alexei Gonzalez-Estrada, Miguel A. Park |
| 102 |
[GO] |
2022―Mar―04 |
SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis |
Gülseren Tuncay, Ozge Can Bostan, Ebru Damadoglu, Gül Karakaya, Ali Fuat Kalyoncu |
| 103 |
[GO] |
2022―Feb―25 |
Medication Adherence in Medicare Enrolled Older Adults with Asthma Before and During the COVID-19 Pandemic |
Olivia L. Ramey, Armando Silva Almodóvar, Milap C. Nahata |
| 104 |
[GO] |
2022―Feb―25 |
Effects of COVID-19 Pandemic on Children, Adolescents and Young Adults with Asthma in Rhode Island: Patterns in Emergency Department Utilization with Geospatial Mapping |
Daphne Koinis-Mitchell, Christina D'Angelo, Shira Dunsiger, Elizabeth McQuaid, Michelle L. Rogers |
| 105 |
[GO] |
2022―Feb―25 |
Ultra-rush immunotherapy with polymerized extracts during COVID-19 pandemic: safety of restarting administrations without dose-adjustments |
Mariana Bragança, José Luís Plácido, Luís Amaral |
| 106 |
[GO] |
2022―Feb―22 |
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions |
Anita Kohli-Pamnani, Kristen Zapata, Tiffany Gibson, Pamela L. Kwittken |
| 107 |
[GO] |
2022―Feb―22 |
Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines |
Luc de Chaisemartin, Antoine Diep, Cécile Gonnin, Angèle Soria, Annick Barbaud, Pascale Nicaise-Roland |
| 108 |
[GO] |
2022―Feb―12 |
A COVID-19 Vaccinated Patient with Phosphoinositide 3-Kinase Disease with Mild Illness Following SARS-CoV-2 Infection |
Sandeep Sarkaria, Amanpreet Kalkat, Robert Hostoffer |
| 109 |
[GO] |
2022―Feb―04 |
A Pediatric Asthma Camp Experience during the COVID-19 Pandemic |
Victoria Eng, Gary Paul Moreno, Jinny Chang, Myron Liebhaber |
| 110 |
[GO] |
2022―Jan―31 |
The Effect of COVID-19 on Asthma Visits |
Sean Stout, Helen Murphy, Aarti Pandya, Hung-Wen Yeh, Jay Portnoy |
| 111 |
[GO] |
2021―Dec―29 |
Psychological Impacts of COVID-19 on people with Asthma, Allergic Rhinitis and Food Allergy |
Alyssa G. Burrows, Anne K. Ellis |
| 112 |
[GO] |
2021―Dec―16 |
Impact of COVID-19 pandemic on frequency and severity of asthma exacerbations in an inner-city population |
Stefanie Zaner Fischell, Jonathan M. Fischell, Gloribel Olexa, Charles Callahan, Mary E. Bollinger |
| 113 |
[GO] |
2021―Nov―23 |
Messenger RNA vaccines and neutralizing anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency |
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit |
| 114 |
[GO] |
2021―Nov―20 |
Delayed hypersensitivity to the Comirnaty COVID-19 vaccine presenting with pneumonitis and rash |
Dr Alex Stoyanov, Dr Graeme Thompson, Dr Monique Lee, Professor Connie Katelaris |
| 115 |
[GO] |
2021―Nov―16 |
Utility and Futility of Skin Testing to Address Concerns Surrounding mRNA COVID-19 Vaccine Reactions |
Mitchell M Pitlick, Andrea N Sitek, Michael E D'Netto, Kelley N Dages, Sergio E Chiarella, Alexei Gonzalez-Estrada, Avni Y Joshi, Miguel A Park |
| 116 |
[GO] |
2021―Nov―04 |
D020 ROLE OF CELLULAR CASPASES AND THERAPEUTIC POTENTIAL OF A PAN-CASPASE INHIBITOR, EMRICASAN, IN COVID-19. |
O. Alpan, R. Gupta, M. Latterich, M. Hubka, Z. Bukhari, L. Ndhlovu |
| 117 |
[GO] |
2021―Nov―04 |
M127 A MULTIFACETED APPROACH TO DIAGNOSIS AND MANAGEMENT OF POST COVID-19 ASSOCIATED DYSPNEA IN ADOLESCENTS |
M. Nevid, C. Lomas, N. Rabinovitch |
| 118 |
[GO] |
2021―Nov―04 |
A044 COVID-19 IN CVID: A LARGE HOSPITAL EXPERIENCE |
J. Greenmyer, A. Joshi |
| 119 |
[GO] |
2021―Nov―04 |
P155 ASSOCIATION OF PRIOR COVID-19 INFECTION AND SYSTEMIC SIDE EFFECTS AFTER COVID-19 VACCINATION IN HEALTHCARE POPULATION |
V. Phomakay, J. Lieberman |
| 120 |
[GO] |
2021―Nov―04 |
P003 DIAGNOSTIC UTILITY OF PEG/POLYSORBATE 80 SKIN TESTING AND ORAL CHALLENGE FOR COVID-19 MRNA VACCINE ALLERGY |
J. Ohtola, D. Lang, L. Pien |
| 121 |
[GO] |
2021―Nov―04 |
P191 DERMATITIS RELATED TO PPE UTILIZATION AMONG HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC |
D. Frankel, S. Mawhirt, M. Akerman, L. Fonacier |
| 122 |
[GO] |
2021―Nov―04 |
P173 IMPROVING ACCESS TO HEALTHCARE THROUGH TELEMEDICINE IN AN UNDERSERVED ASTHMA POPULATION DURING THE COVID-19 PANDEMIC |
A. Heffes-Doon, U. Kothari, A. Webb |
| 123 |
[GO] |
2021―Nov―04 |
P001 ALLERGISTS LEAD ANAPHYLAXIS PREPAREDNESS VIRTUAL WORKSHOPS FOR EARLY CHILDHOOD PROFESSIONALS AMIDST THE COVID-19 PANDEMIC |
M. Duggins, R. Shah, M. Baker, M. Marget, M. Oxford, A. Hoyt |
| 124 |
[GO] |
2021―Nov―04 |
A005 PATCH TESTING RESULTS IN ADULT PATIENTS WITH DERMATITIS DURING THE COVID-19 PANDEMIC |
S. Kong, S. Mawhirt, S. Islam |
| 125 |
[GO] |
2021―Nov―04 |
P091 BIOMARKERS OF INFLAMMATION AND IMMUNE REGULATION IN COVID-19 PATIENTS AND COVID 19 VACCINATED INDIVIDUALS |
M. Trusevich, L. Titov, T. Amvrosieva, I. Belskaya, L. DuBuske |
| 126 |
[GO] |
2021―Nov―04 |
P154 TREATING COVID-19 PNEUMONIA WITH DOXYCYCLINE DOES NOT IMPROVE MORTALITY |
M. Majzoub, R. Joks |
| 127 |
[GO] |
2021―Nov―04 |
M102 A CASE OF DELAYED UVULAR ANGIOEDEMA AFTER ADMINISTRATION OF THE COVID-19 VACCINE |
S. Kim, N. Mambetsariev, L. Grammer |
| 128 |
[GO] |
2021―Nov―04 |
M044 POLYETHYLENE GLYCOL ALLERGY TESTING AN ADOLESCENT WITH ANAPHYLAXIS TO PEG-ASPARAGINASE BEFORE ADMINISTERING PFIZER-BIONTECH COVID-19 VACCINE |
M. Breidenbaugh |
| 129 |
[GO] |
2021―Nov―04 |
P006 POLYETHYLENE GLYCOL ALLERGY LABEL: NOT AN ABSOLUTE CONTRAINDICATION TO RECEIVING AN MRNA COVID-19 VACCINE |
M. Pitlick, K. Dages, A. Joshi, M. Park |
| 130 |
[GO] |
2021―Nov―04 |
A001 MRNA COVID-19 VACCINE ADVERSE EVENTS FOLLOWING IMMUNIZATION: SHOULD YOU RECOMMEND THE SECOND DOSE? |
B. St. Clair, D. Hoffman, R. Lee, J. Montgomery |
| 131 |
[GO] |
2021―Nov―04 |
P177 COVID-19 VACCINE ADVERSE REACTIONS IN HOSPITAL EMPLOYEES |
H. Jin, M. Ackerman, M. Phillips, C. Cohan, S. Salvati, M. Wilkenfeld, L. Fonacier |
| 132 |
[GO] |
2021―Nov―04 |
M260 EVALUATION OF THE HYPERSENSITIVITY RISK OF THE COVID-19 VACCINE COMPONENTS: A SERIES OF CASE REPORTS |
T. Delgado Guzmán, S. Gonzalez-Diaz, R. Villarreal Gonzalez, C. De Lira-Quezada, A. Chávez Ruiz, C. Macouzet-Sanchez |
| 133 |
[GO] |
2021―Nov―04 |
M098 A CASE OF HEREDITARY A-TRYPTASEMIA EXACERBATION FOLLOWING SECOND DOSE OF MRNA COVID-19 VACCINE ON OMALIZUMAB |
J. Li, R. Saff |
| 134 |
[GO] |
2021―Nov―04 |
M275 COVID-19 VACCINE RELATED URTICARIAL VASCULITIS |
S. Bhatti, J. McCracken |
| 135 |
[GO] |
2021―Nov―04 |
M015 A PATIENT WITH AN ALLERGIC REACTION TO THE PFIZER COVID-19 VACCINE SUBSEQUENTLY TOLERATES JOHNSON&JOHNSON VACCINATION |
A. Patterson, Z. Ren, M. Jerath |
| 136 |
[GO] |
2021―Nov―04 |
M019 COVID-19 VACCINE-ASSOCIATED ANAPHYLAXIS: BASOPHIL ACTIVATION IN A SPECIFIC IGE AND IGG NEGATIVE PATIENT |
S. Jiang, E. Smith, V. Vo, V. Sampath, T. Snow, M. Shah, A. Heider, C. Akdis, K. Nadeau |
| 137 |
[GO] |
2021―Nov―04 |
M004 UNUSUAL ANAPHYLACTIC REACTION TO COVID-19 VACCINE-CONSTRUCTING A HISTORY WITH TECHNOLOGY AS AN AID |
E. Montgomery, D. Sheth |
| 138 |
[GO] |
2021―Nov―04 |
P095 LEVELS OF IGG TO SARS-COV-2 IN RECIPIENTS OF COVID-19 VACCINES: LONGITUDINAL MONITORING WITH QUANTITATIVE ASSAY |
J. Patel, B. Keshavarz, N. Richards, L. Workman, L. Muehling, D. Murphy, W. Eschenbacher, M. Nelson, T. Platts-Mills, J. Wilson |
| 139 |
[GO] |
2021―Nov―04 |
P094 IMMUNOLOGIC EFFICACY OF POOLED MESENCHYMAL STEM CELLS IN PATIENTS WITH SEVERE COVID-19-ASSOCIATED PNEUMONIA |
A. Rynda, A. Hancharou, N. Antonevich, S. Aliakseichyk, Y. Pankratova, V. Isachkin, L. DuBuske |
| 140 |
[GO] |
2021―Nov―04 |
P096 LIPOPOLYSACCHARIDE-BINDING SYSTEMS IN PATIENTS WITH SARS-COV-19 INFECTION HAVING VARIOUS DEGREES OF SEVERITY |
V. Beloglazov, I. Yatskov, A. Nikolaeva, E. Lavrenchuk, L. DuBuske |
| 141 |
[GO] |
2021―Nov―04 |
A041 DETECTION OF SARS-COV-2 ANTIBODIES IN IMMUNOGLOBULIN PRODUCTS |
K. Cousins, K. Sano, G. Singh, N. Aboelregal, S. Jeong, H. Ho, F. Krammer, C. Cunningham-Rundles |
| 142 |
[GO] |
2021―Nov―04 |
A045 INADEQUATE SARS-COV-2 ANTIBODY RESPONSE TO MRNA SARS-COV-2 VACCINE IN ADOLESCENT KIDNEY TRANSPLANT RECIPIENTS |
L. Loop, C. Crane, C. Anterasian, B. Geng, E. Ingulli |
| 143 |
[GO] |
2021―Nov―04 |
M013 SUCCESSFUL FOUR-STEP GRADED-DOSE ADMINISTRATION TO THE PFIZER-MRNA SARS-COV-2 VACCINE IN A PATIENT WITH PREVIOUS ANAPHYLAXIS |
D. Morgenstern-Kaplan, I. Carrillo-Martin, C. Rivera, M. Parkulo, A. Gonzalez-Estrada |
| 144 |
[GO] |
2021―Nov―04 |
M010 DIAGNOSTIC CHALLENGE IN EVALUATING THE RISK AND MANAGEMENT OF ALLERGIC REACTION(S) TO SARS-COV-2 VACCINES |
E. Abou-Jaoude, T. Nsouli, N. Diliberto, S. Nsouli, J. Bellanti |
| 145 |
[GO] |
2021―Nov―04 |
M191 IMMUNE ASSESSMENT IN POST-ACUTE SEQUALA OF SARS-COV2 INFECTION (PASC): EVIDENCE OF PERSISTENT IMMUNE ACTIVATION? |
V. Ahluwalia, V. Iyer, A. Joshi |
| 146 |
[GO] |
2021―Oct―28 |
Atopic comorbidity has no impact on severity and course of COVID-19 disease in adult patients |
Julia Zarnowski, Paula Kage, Jan-Christoph Simon, Regina Treudler |
| 147 |
[GO] |
2021―Oct―25 |
The COVID-19 Pandemic: Adverse Effects on the Social Determinants of Health in Children and Families |
Elissa M Abrams, Matthew Greenhawt, Marcus Shaker, Andrew D Pinto, Ian Sinha, Alexander Singer |
| 148 |
[GO] |
2021―Oct―25 |
Allergic reactions to COVID-19 vaccines and addressing vaccine hesitancy: Northwell Health experience |
Blanka Kaplan, Sherry Farzan, Gina Coscia, David W. Rosenthal, Alissa McInerney, Artemio M. Jongco, Punita Ponda, Vincent R. Bonagura |
| 149 |
[GO] |
2021―Oct―25 |
Delayed angioedema following SARS-CoV-2 mRNA vaccine administration |
Melissa M. Watts, Laura E. Maurer, Leslie C. Grammer, Carol A. Saltoun, Whitney W. Stevens |
| 150 |
[GO] |
2021―Oct―19 |
Asthma in older adults with severe COVID-19: clinical outcomes and predictors of mortality. |
Sergey N. Avdeev, Anna A. Pozdnakova, Viliya V. Gaynitdinova, Svetlana Yu Chikina, Anna E. Vlasenko |
| 151 |
[GO] |
2021―Oct―13 |
Trends in racial disparities in asthma emergency department utilization during COVID-19 |
Rubayet Hossain, Fang Zhao, Marie Michenkova, David Kaelber, Yasir Tarabichi |
| 152 |
[GO] |
2021―Oct―13 |
Polyethylene glycol and polysorbate testing in twelve patients prior to or after COVID-19 vaccine administration |
Taya Carpenter, Justin Konig, Jillian Hochfelder, Subhadra Siegel, Melissa Gans |
| 153 |
[GO] |
2021―Sep―30 |
Evaluation of Anaphylaxis Risk by Skin Testing with Covid-19 mRNA Vaccines on Anaphylactic Patients |
Marek M. Pienkowski, Stefan M. Pienkowski |
| 154 |
[GO] |
2021―Sep―27 |
National decline in asthma exacerbations in US during COVID19 pandemic |
Regina W Lam, Jonathan W Inselman, Molly M Jeffery, Jacob T Maddux, Matthew A Rank |
| 155 |
[GO] |
2021―Sep―20 |
Non-IgE mediated allergy associated with Pfizer-BioNTech COVID-19 vaccine excipient polyethylene glycol |
Shirley Y. Jiang, Eric M. Smith, Victor Vo, Cezmi Akdis, Kari C. Nadeau |
| 156 |
[GO] |
2021―Sep―03 |
COVID-19 Vaccine Hypersensitivity Evaluated with Vaccine and Excipients Allergy Skin Testing |
Anita Kohli-Pamnani, Kristen Zapata, Tiffany Gibson, Pamela L. Kwittken |
| 157 |
[GO] |
2021―Aug―01 |
Eosinophilic inflammation, coronavirus disease 2019, and asthma |
Sanjay Ramakrishnan, Mona Bafadhel |
| 158 |
[GO] |
2021―Jul―31 |
Specific antibody response of common variable immunodeficiency patients to BNT162b2 COVID-19 vaccination |
Nizar Abo-helo, Emad Muhammad, Sondus Ghaben-amara, Josef Panasoff, Shai Cohen |
| 159 |
[GO] |
2021―Jul―31 |
Biphasic anaphylaxis after first dose of mRNA COVID-19 vaccine with positive polysorbate 80 skin testing |
Mitchell M Pitlick, Miguel A Park, Alexei Gonzalez-Estrada, Sergio E Chiarella |
| 160 |
[GO] |
2021―Jul―11 |
Anaphylaxis-related knowledge and concerns in Canadian families during COVID-19 |
Sofianne Gabrielli, Jennifer LP Protudjer, Gregory Gooding, Jennifer Gerdts, Moshe Ben-Shoshan |
| 161 |
[GO] |
2021―Jun―20 |
Telemedicine During the COVID-19 Pandemic for Pediatric Eosinophilic Esophagitis Patients |
Anupama Kewalramani, Jaylyn Waddell, Elaine Leonard Puppa |
| 162 |
[GO] |
2021―Jun―18 |
Eosinophils in antiviral immunity and (perhaps) a benefit of having asthma during the SARS-CoV2 pandemic |
Ryan Eid, Larry Borish |
| 163 |
[GO] |
2021―May―19 |
Seroconversion Following COVID-19 Vaccination in Immune Deficient Patients |
Jacqueline Squire, Dr. Avni Joshi |
| 164 |
[GO] |
2021―May―18 |
Skin Prick Test Practice In Allergy Clinics During Covid-19 Pandemic |
Resat Kendirlinan, Pamir Cerci, Dilsad Mungan |
| 165 |
[GO] |
2021―May―16 |
Home epinephrine-treated reactions in food allergy oral immunotherapy: Lessons from COVID-19 lockdown |
Liat Nachshon, Michael R Goldberg, Michael B Levy, Naama Epstein-Rigbi, Yael Koren, Arnon Elizur |
| 166 |
[GO] |
2021―May―08 |
Commentary on Eosinophilic inflammation, COVID-19, and asthma - are inhaled corticosteroids the missing link? |
Kam Sing Ho, Daniel Howell, Linda Rogers, Bharat Narasimhan, Hannah Verma, David Steiger |
| 167 |
[GO] |
2021―May―07 |
Investigating Air Pollution as a Contributor to Health Disparities During the COVID-19 Pandemic |
Harleen Marwah, Natalie Rosseau, Sowmya Mangipudi, Caitlin Ward, Anjeni Keswani |
| 168 |
[GO] |
2021―May―05 |
Risk of allergic reaction in patients with atopic disease and recent COVID-19 vaccination |
Kelley N. Dages, Mitchell M. Pitlick, Avni Y. Joshi, Miguel A. Park |
| 169 |
[GO] |
2021―May―01 |
The evidence is in that asthma is not associated with severe coronavirus disease 2019 |
Dylan T. Timberlake, Mitchell H. Grayson |
| 170 |
[GO] |
2021―Apr―08 |
Disproportionality Analysis of Anaphylactic Reactions after Vaccination with mRNA COVID-19 Vaccines in the United States |
Guillermo Rodriguez-Nava, Goar Egoryan, Daniela Patricia Trelles-Garcia, Maria Adriana Yanez-Bello, Ricardo Murguia-Fuentes |
| 171 |
[GO] |
2021―Mar―27 |
Drug Desensitization in the Covid-19 Pandemic Era: Local Success to Widespread Potential |
Kimberly G. Blumenthal, Mariana Castells, Aleena Banerji |
| 172 |
[GO] |
2021―Mar―27 |
Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines |
John M Kelso |
| 173 |
[GO] |
2021―Mar―26 |
Evaluating the impact of COVID-19 on asthma morbidity: a comprehensive analysis of potential influencing factors |
Olga L Guijon, Tricia Morphew, Morphew Consulting, Louis Ehwerhemuepha, Stanley P Galant |
| 174 |
[GO] |
2021―Mar―26 |
Polyethylene Glycol and Polysorbate Skin Testing in the Evaluation of COVID-19 Vaccine Reactions: Early Report |
Mitchell M Pitlick, Andrea N Sitek, Susan A Kinate, Avni Y Joshi, Miguel A Park |
| 175 |
[GO] |
2021―Mar―26 |
Prepping for a pandemic |
Kelsey Lecerf, Mitchell H. Grayson |
| 176 |
[GO] |
2021―Feb―27 |
The Relationship Between Asthma, Eosinophilia, and Outcomes in COVID-19 Infection |
Kam Sing Ho, Daniel Howell, Linda Rogers, Bharat Narasimhan, Hannah Verma, David Steiger |
| 177 |
[GO] |
2021―Feb―25 |
Asthma in COVID-19 suspected and diagnosed patients |
Lijuan Cao, Sandra Lee, James G. Krings, Adriana M. Rauseo, Daniel Reynolds, Rachel Presti, Charles Goss, Philip A. Mudd, Jane A. O'Halloran, Leyao Wang |
| 178 |
[GO] |
2021―Feb―19 |
Asthma in patients with coronavirus disease 2019: a systematic review and meta-analysis |
Li Shi, Jie Xu, Wenwei Xiao, Ying Wang, Yuefei Jin, Shuaiyin Chen, Guangcai Duan, Haiyan Yang, Yadong Wang |
| 179 |
[GO] |
2021―Jan―23 |
Asthma and allergic diseases are not risk factors for hospitalization in children with COVID-19 |
Burcin Beken, Gokcen Kartal Ozturk, Fatma Deniz Aygun, Cigdem Aydogmus, Himmet Haluk Akar |
| 180 |
[GO] |
2021―Jan―23 |
Effect of Patient and Parental Anxiety on Adherence to Subcutaneous Allergen Immunotherapy During COVID-19 Pandemic |
Ilknur Kulhas Celik, Azize Pinar Metbulut, Ozden Sukran Uneri, Gulser Senses Dinc, Emine Dibek Misirlioglu |
| 181 |
[GO] |
2021―Jan―23 |
Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines: Allergic Reactions to mRNA SARS-CoV-2 Vaccines |
Kevin R. Murphy, Niraj C. Patel, Daniel Ein, Mary Hudelson, Sangeetha Kodoth, Gailen D. Marshall, Purvi Parikh, Michael S. Blaiss |
| 182 |
[GO] |
2021―Jan―14 |
SARS-CoV2 infection in those on Mepolizumab therapy |
Adnan Azim, Laura Pini, Zeeshan Khakwani, Santosh Kumar, Peter Howarth |
| 183 |
[GO] |
2020―Dec―30 |
Monitoring Neutrophil to Lymphocyte Ratio in COVID-19 Patients Receiving Tocilizumab |
Nicholas L. Hartog, Alan T. Davis, Jeremy W. Prokop, Andrew Walls, Surender Rajasekaran |
| 184 |
[GO] |
2020―Dec―11 |
Zoonotic coronavirus epidemics: SARS, MERS, and COVID-19 |
Monica Fung, Iris Otani, Michele Pham, Jennifer Babik |
| 185 |
[GO] |
2020―Nov―22 |
Non-neutralizing antibodies and limitations of serological testing for SARS-CoV-2 in patients receiving replacement immunoglobulin products |
Deepti Vellaichamy Manian, Chelsee Jensen, Elitza S. Theel, John R. Mills, Avni Joshi |
| 186 |
[GO] |
2020―Nov―13 |
P350 EFFECTS OF ATOPIC DISEASE ON DISEASE SEVERITY IN COVID-19 |
D. Timberlake, D. Narayanan, P. Ogbogu, R. Raveendran, B. Prince, R. Scherzer, K. Porter, M. Grayson |
| 187 |
[GO] |
2020―Nov―13 |
M030 RITUXIMAB-INDUCED SERUM SICKNESS IN A PEDIATRIC PATIENT WITH MULTIPLE AUTOIMMUNE DISEASES AND HISTORY OF COVID-19 |
K. Nguyen, A. Kazatsky |
| 188 |
[GO] |
2020―Nov―13 |
M412 A BALANCING ACT: TREATMENT OF COVID-19 AND CYTOMEGALOVIRUS IN A PATIENT WITH PRIMARY IMMUNODEFICIENCY |
V. Szafron, M. Pereira, T. Vogel, D. Leung, L. Forbes-Satter |
| 189 |
[GO] |
2020―Nov―13 |
A050 THE IMPACT OF COVID-19 AND DISEASE CONTROL MEASURES ON PEDIATRIC FOOD ALLERGY PARENTS/CAREGIVERS AND PATIENTS |
C. Warren, S. Chinthrajah, P. Newmark, L. Herbert, S. Fox, K. Nadeau, H. Sharma, A. Assa'ad, M. Tobin, R. Gupta |
| 190 |
[GO] |
2020―Nov―13 |
M405 COVID-19 ASSOCIATED EOSINOPHILIC LICHEN PLANUS |
G. Hudes, M. Weingarten, D. Sanchez Tejera |
| 191 |
[GO] |
2020―Nov―13 |
M402 FACIAL CONTACT DERMATITIS DUE TO MASKS IN THE COVID-19 ERA |
Y. Dhamija, N. Khan, K. Schmidlin |
| 192 |
[GO] |
2020―Nov―13 |
M413 COVID-19 IN A PATIENT WITH CVID AND CONTRAINDICATIONS TO SEVERAL POTENTIAL TREATMENTS |
E. Ender, P. Timothy |
| 193 |
[GO] |
2020―Nov―13 |
M403 COVID-19 IN A PATIENT WITH HYPER-EOSINOPHILIC SYNDROME TREATED WITH MEPOLIZUMAB |
Z. Khakwani, S. Kumar |
| 194 |
[GO] |
2020―Nov―13 |
M410 COVID-19 INFECTION IN A PATIENT WITH SECONDARY HYPOGAMMAGLOBULINEMIA |
D. Maghen, G. Lutz, A. Schneider |
| 195 |
[GO] |
2020―Nov―13 |
M406 SELF-LIMITED COVID-19 INFECTION IN ARTEMIS HYPOMORPHIC SCID: ARE B CELLS DISPENSABLE? |
S. Gabryszewski, D. Sun, S. Jyonouchi, K. Sullivan, S. Henrickson |
| 196 |
[GO] |
2020―Nov―13 |
M400 MANAGING A CASE OF REPORTED LOCAL LIDOCAINE ALLERGY IN A PREGNANT WOMAN DURING COVID-19 PANDEMIC |
H. Jin, O. Waqar, R. Miller |
| 197 |
[GO] |
2020―Nov―13 |
M409 ELECTRONIC CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY AMIDST THE COVID-19 PANDEMIC |
A. Diaz, S. Sani, S. Mawhirt |
| 198 |
[GO] |
2020―Nov―13 |
P201 PERCEIVED APATHY FROM PHYSICIANS ASSOCIATED WITH EMOTIONAL DISTRESS AMID COVID-19 PANDEMIC IN ADULTS WITH ASTHMA |
S. Alonzi, T. Coaston, M. Silverstein |
| 199 |
[GO] |
2020―Nov―13 |
M414 LOMATIUM DISSECTUM RASH: A COMPLICATION OF COVID-19 PROPHYLAXIS THERAPY |
J. Nelson |
| 200 |
[GO] |
2020―Nov―13 |
M408 AN UNUSUAL MISSED DIAGNOSIS OF MULTIFACETED CLINICAL CASE OF CORONAVIRUS DISEASE 2019 MIMICKING UNCONTROLLED ASTHMA |
S. Nsouli |
| 201 |
[GO] |
2020―Nov―13 |
M407 COMPLICATIONS OF CORONAVIRUS IN A PATIENT WITH CVID |
D. Urschel, M. Cardenas-Morales, V. Hernandez-Trujillo |
| 202 |
[GO] |
2020―Nov―13 |
M411 ACTIVE TUBERCULOSIS (TB) MASQUERADING AS AN ASTHMA EXACERBATION DURING A SARS-COV-2 (COVID 19) PANDEMIC |
G. Hudes, M. Beronilla |
| 203 |
[GO] |
2020―Nov―13 |
M404 PERSISTENT POSITIVITY OF SARS-COV-2 NASOPHARYNGEAL PCR TEST IN A CHILD WITH ASTHMA |
M. Pitlick, A. Joshi |
| 204 |
[GO] |
2020―Nov―13 |
A060 INNER CITY ASTHMA TELE-MEDICINE DURING COVID PANDEMIC |
K. Kwong |
| 205 |
[GO] |
2020―Nov―06 |
Potential Association of Mast Cells with COVID-19 |
Theoharis C. Theoharides |
| 206 |
[GO] |
2020―Nov―05 |
Controlled Trials Needed to Prove Efficacy and Safety of Convalescent Plasma Therapy in COVID-19 |
Nicholas Hartog, Amanda Holsworth, Surender Rajasekaran |
| 207 |
[GO] |
2020―Oct―12 |
Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019 |
Jamie A. Rosenthal, Seemal F. Awan, Jonathan Fintzi, Anjeni Keswani, Daniel Ein |
| 208 |
[GO] |
2020―Sep―18 |
High anxiety and health-related quality-of-life in families with children with food allergy during COVID-19 |
J.L.P. Protudjer, M. Golding, M.R. Salisbury, E.M. Abrams, L.E. Roos |
| 209 |
[GO] |
2020―Sep―07 |
Differentiating characteristics of asthmatic patients in the SARS-CoV2 infection. |
José Lemus Calderón, Pedro Beneyto Martin, Raúl Guzmán Rodriguez, Horacio Caligaris Cataldi, Carlos Senent Sánchez |
| 210 |
[GO] |
2020―Aug―25 |
U.S. Public Health Resources for COVID-19 That Are Relevant to Allergy/Immunology |
Joy Hsu |
| 211 |
[GO] |
2020―Aug―25 |
Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019 |
Giorgio Ciprandi, Amelia Licari, Gaetana Filippelli, Maria Angela Tosca, Gian Luigi Marseglia |
| 212 |
[GO] |
2020―Aug―18 |
A fatal case of COVID-19 in a patient with common variable immunodeficiency |
Jyotsna Mullur, Alberta Wang, Anna Feldweg |
| 213 |
[GO] |
2020―Aug―17 |
Perceived stress links income loss and urticaria activity during the COVID-19 pandemic |
Minxue Shen, Yangjian Xiao, Yan Yuan, Xiang Chen, Jie Li |
| 214 |
[GO] |
2020―Aug―01 |
Anaphylactic shock following diagnosis of COVID-19 |
Alberto Alvarez-Perea, María Luisa Baeza |
| 215 |
[GO] |
2020―Aug―01 |
Clinical course and outcomes in patients with asthma hospitalized for SARS-CoV-2 pneumonia:a single-center, retrospective study. |
Carlo Lombardi, Elena Roca, Barbara Bigni, Marcello Cottini, Giovanni Passalacqua |
| 216 |
[GO] |
2020―Jul―24 |
Smell loss is a prognostic factor for lower severity of COVID-19 |
Katharine J. Foster, Emilio Jauregui, Bobby Tajudeen, Faraz Bishehsari, Mahboobeh Mahdavinia |
| 217 |
[GO] |
2020―Jul―22 |
COVID-19 - associated urticaria with angioedema in a morbidly obese male successfully treated with glucocorticoids |
Richard F. Lockey, Stephanie N. Hudey |
| 218 |
[GO] |
2020―Jul―18 |
Atopy is predictive of a decreased need for hospitalization for COVID-19 |
Anjeni Keswani, Klodian Dhana, Jamie A. Rosenthal, Donyea Moore, Mahboobeh Mahdavinia |
| 219 |
[GO] |
2020―Jul―01 |
Idiopathic Nonhistaminergic Acquired Angioedema in a Patient with COVID-19 |
Veronica Azmy, Jemma Benson, Keith Love, Ryan Steele |
| 220 |
[GO] |
2020―Jul―01 |
Use of inhaled corticosteroids in asthma and coronavirus disease 2019 |
Brian Lipworth, Rory Chan, Chris RuiWen Kuo |
| 221 |
[GO] |
2020―Jun―22 |
Patient Satisfaction with Telemedicine Encounters in an Allergy/Immunology Practice During the COVID-19 Pandemic |
S. Shahzad Mustafa, Luanna Yang, Mahta Mortezavi, Karthik Vadamalai, Allison Ramsey |
| 222 |
[GO] |
2020―Jun―14 |
COVID-19, SEVERE ASTHMA AND BIOLOGICS |
Ismael García-Moguel, Rocío Díaz Campos, Sergio Alonso Charterina, Consuelo Fernández Rodríguez, Jesús Fernández Crespo |
| 223 |
[GO] |
2020―Jun―10 |
COVID-19 and allergen immunotherapy: theoretical benefits invite to adjustments in practice recommendations |
Désirée Larenas-Linnemann, Noel Rodríguez-Pérez, Jose Antonio Ortega-Martell, Virginia Blandon Vijil, Jorge A. Luna-Pech |
| 224 |
[GO] |
2020―Jun―04 |
Positive Outcome in a COVID-19 patient with Common Variable Immunodeficiency after IVIG |
Rana Aljaberi, Kholoud Wishah |
| 225 |
[GO] |
2020―May―27 |
Rethinking Respiratory Function Test Lab in the Era of COVID-19 : considerations about the “today” and the “day after” |
Lombardi Carlo, Milanese Manlio, Cottini Marcello |
| 226 |
[GO] |
2020―May―22 |
Drug allergy labeling and delabeling in the coronavirus disease 2019 era |
Mariana C. Castells |
| 227 |
[GO] |
2020―May―11 |
Clinical course of asthma in 4 cases of COVID-19 infection |
Christopher D. Codispoti, Sindhura Bandi, Payal Patel, Mahboobeh Mahdavinia |
| 228 |
[GO] |
2020―May―06 |
Dietary Management of Food Protein-Induced Enterocolitis Syndrome during COVID-19 Pandemic |
Marion Groetch, Raquel Durban, Rosan Meyer, Carina Venter, Anna Nowak-Wegrzyn |
| 229 |
[GO] |
2020―May―06 |
Asthma, biologics, corticosteroids, and coronavirus disease 2019 |
Ayobami T. Akenroye, Robert Wood, Corinne Keet |
| 230 |
[GO] |
2020―May―05 |
The Clinical Observation of a CVID Patient Infected with COVID-19 |
Lauren Fill, Lauren Hadney, Kelsey Graven, Roberta Persaud, Robert Hostoffer |
| 231 |
[GO] |
2020―May―05 |
Managing FPIES during the COVID-19 pandemic-expert recommendations |
A. Nowak-Wegrzyn, A. Cianferoni, J.A. Bird, A. Fiocchi, J.C. Caubet, Stefania Arasi, Ashis V. Barad, Theresa Bingemann, Terri Brown-Whitehorn, Raquel Durban, Todd Green, George Konstantinou, Stephanie Leonard, Jennifer Lightdale, Antonella Muraro, Ichiro Nomura, Jonathan Spergel, Carina Venter |
